Embera NeuroTherapeutics
Embera NeuroTherapeutics, Inc..
Launch date
Employees
Market cap
-
Enterprise valuation
CAD13—19m (Dealroom.co estimates Feb 2015.)
Sudbury Massachusetts (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $800k | Early VC | |
| N/A | $800k | Series A | |
| N/A | $300k | Debt | |
| N/A | $400k | Debt | |
| N/A | $100k | Seed | |
| N/A | $490k | Series A | |
| N/A | $4.5m | Series A | |
| N/A | N/A | Grant | |
$2.3m | Series A | ||
| N/A | $2.0m | Early VC | |
N/A | Debt | ||
| N/A | N/A | Seed | |
N/A | Grant | ||
| N/A | N/A | Series A | |
$1.3m | Series A | ||
| Total Funding | CAD16.7m | ||
Related Content
Recent News about Embera NeuroTherapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.